The study analyzed blood, plasma, and urine samples from 88 women, including those with two or more consecutive miscarriages and healthy controls. Using ultra-high performance liquid chromatography paired with tandem mass spectrometry, the team quantified 25 NAD-related metabolites. Sophisticated statistical analyses, including partial least-squares discriminant analysis and machine learning, identified three key metabolites—1-methylnicotinamide (1MNA) and its derivatives-differing significantly between groups. These changes were independent of vitamin B3 supplementation, suggesting fundamental metabolic disruptions. Elevated plasma 1MNA levels correlated with a 2% higher miscarriage risk per unit increase.
Building on earlier discoveries that low NAD levels cause developmental defects in mice, this research reveals a more nuanced picture in humans involving altered vitamin B3 metabolism rather than simple deficiency. The study’s methodological strength lies in its multi-sample design, advanced metabolomic profiling, and robust statistical approach, enhancing confidence in findings despite modest sample size.
With funding secured for a three-year longitudinal follow-up starting in 2026, researchers will explore NAD biomarkers, dietary impacts, and other clinical factors in larger cohorts, including women currently experiencing miscarriages. Ultimately, this work aims to develop predictive tests and targeted interventions to reduce recurrent pregnancy loss, offering tangible hope for families.
This discovery dramatically advances our molecular understanding of miscarriage risk, heralding new precision medicine approaches to protect maternal and fetal health.
REFERENCE: Cuny, H., et al. (2025). Identification of potential NAD-related biomarkers of recurrent miscarriage risk. Human Reproduction. doi: 10.1093/humrep/deaf195. https://academic.oup.com/humrep/advance-article/doi/10.1093/humrep/deaf195/8307317
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.